These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21308147)

  • 1. A four-gene signature predicts disease progression in muscle invasive bladder cancer.
    Kim WJ; Kim SK; Jeong P; Yun SJ; Cho IC; Kim IY; Moon SK; Um HD; Choi YH
    Mol Med; 2011; 17(5-6):478-85. PubMed ID: 21308147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 13‑mRNA signature for predicting disease progression and prognosis in patients with bladder cancer.
    Yin H; Zhang C; Gou X; He W; Gan D
    Oncol Rep; 2020 Feb; 43(2):379-394. PubMed ID: 31894276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.
    Worst TS; Weis CA; Stöhr R; Bertz S; Eckstein M; Otto W; Breyer J; Hartmann A; Bolenz C; Wirtz RM; Erben P
    Sci Rep; 2018 Sep; 8(1):14383. PubMed ID: 30258198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs.
    Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Alber G; Kiefer I; Steiner JM; Seeger J; Heilmann RM
    BMC Vet Res; 2023 Nov; 19(1):234. PubMed ID: 37946179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Overall Survival Prediction Signature Based on Comprehensive Research in Prostate Cancer Bone Metastases.
    Hu K; Hu X; Duan Y; Li W; Qian J; Chen J
    Front Med (Lausanne); 2022; 9():815541. PubMed ID: 35783639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.
    Zhang Y; Lin Y; Lv D; Wu X; Li W; Wang X; Jiang D
    PeerJ; 2022; 10():e12843. PubMed ID: 35127296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression.
    Park S; Rong L; Owczarek TB; Bernardo MD; Shoulson RL; Chua CW; Kim JY; Lankarani A; Chakrapani P; Syed T; McKiernan JM; Solit DB; Shen MM; Al-Ahmadie HA; Abate-Shen C
    Cancer Res; 2021 Oct; 81(20):5161-5175. PubMed ID: 34470779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
    Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYR61 as a potential biomarker for the preoperative identification of muscle-invasive bladder cancers.
    Chen H; Liu Y; Cao C; Xi H; Chen W; Zheng W; Dong X; Zheng S; Li L; Ma J; Gao Y; Shou J
    Ann Transl Med; 2021 May; 9(9):761. PubMed ID: 34268374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Role of S100A8 in Human Solid Cancers: A Systematic Review and Validation.
    Huang A; Fan W; Liu J; Huang B; Cheng Q; Wang P; Duan Y; Ma T; Chen L; Wang Y; Yu M
    Front Oncol; 2020; 10():564248. PubMed ID: 33240811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis related gene expression significantly associated with the prognostic role of an urothelial bladder carcinoma.
    Wang J; Guo M; Zhou X; Ding Z; Chen X; Jiao Y; Ying W; Wu S; Zhang X; Geng N
    Transl Androl Urol; 2020 Oct; 9(5):2200-2210. PubMed ID: 33209684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma.
    Johnson RM; Phillips HS; Bais C; Brennan CW; Cloughesy TF; Daemen A; Herrlinger U; Jenkins RB; Lai A; Mancao C; Weller M; Wick W; Bourgon R; Garcia J
    Neuro Oncol; 2020 Dec; 22(12):1742-1756. PubMed ID: 32897363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel tumor suppressing gene,
    Piao XM; Jeong P; Yan C; Kim YH; Byun YJ; Xu Y; Kang HW; Seo SP; Kim WT; Lee JY; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
    Oncol Lett; 2020 Jan; 19(1):476-486. PubMed ID: 31897161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of gene expression profiles reveals prognostic stratification and underlying mechanisms for muscle-invasive bladder cancer.
    Zhang PB; Huang ZL; Xu YH; Huang J; Huang XY; Huang XY
    Cancer Cell Int; 2019; 19():337. PubMed ID: 31866765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I-III Bladder Cancer Patients After Surgical Resection.
    Li Y; Zhang H; Guo Y; Cai H; Li X; He J; Lai HM; Guan Q; Wang X; Guo Z
    Front Oncol; 2019; 9():629. PubMed ID: 31355144
    [No Abstract]   [Full Text] [Related]  

  • 16. Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).
    Nicklas AP; Kramer MW; Serth J; Hennenlotter J; Hupe MC; Reimer DU; Stenzl A; Merseburger AS; Kuczyk MA; von Klot CJ
    Adv Ther; 2018 Nov; 35(11):2054-2068. PubMed ID: 30232708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
    Huang Y; Zhou S; He C; Deng J; Tao T; Su Q; Darko KO; Peng M; Yang X
    Cancer Commun (Lond); 2018 Jul; 38(1):50. PubMed ID: 30053908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of
    Zhang W; Chen M; Cheng H; Shen Q; Wang Y; Zhu X
    Cancer Manag Res; 2018; 10():323-338. PubMed ID: 29497331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer.
    Lee MS; Lee J; Lee S; Yoo SM; Kim JH; Kim WT; Kim WJ; Park J
    Oncotarget; 2018 Jan; 9(8):7961-7974. PubMed ID: 29487706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
    Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
    Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.